Carolinas Wealth Consulting’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,506
Closed -$63.5K 680
2025
Q1
$63.5K Sell
2,506
-485
-16% -$12.7K 0.01% 318
2024
Q4
$79.4K Buy
2,991
+151
+5% +$4.1K 0.02% 289
2024
Q3
$82.2K Buy
2,840
+124
+5% +$3.62K 0.01% 293
2024
Q2
$76K Sell
2,716
-2,265
-45% -$62.4K 0.01% 303
2024
Q1
$138K Sell
4,981
-10,584
-68% -$294K 0.03% 222
2023
Q4
$141K Sell
15,565
-142
-0.9% -$4.29K 0.03% 194
2023
Q3
$154K Buy
15,707
+881
+6% +$31.2K 0.04% 174
2023
Q2
$150K Sell
14,826
-1,015
-6% -$39.5K 0.03% 207
2023
Q1
$207K Buy
15,841
+1,073
+7% +$46.3K 0.04% 171
2022
Q4
$202K Sell
14,768
-13
-0.1% -$623 0.05% 161
2022
Q3
$175K Sell
14,781
-57
-0.4% -$2.77K 0.04% 168
2022
Q2
$210K Buy
14,838
+10,917
+278% +$556K 0.05% 154
2022
Q1
$203K Buy
3,921
+19
+0.5% +$986 0.04% 167
2021
Q4
$230K Buy
3,902
+366
+10% +$18.1K 0.05% 158
2021
Q3
$152K Sell
3,536
-2,543
-42% -$113K 0.04% 188
2021
Q2
$238K Sell
6,079
-277
-4% -$10.8K 0.05% 151
2021
Q1
$230K Buy
6,356
+185
+3% +$6.57K 0.06% 150
2020
Q4
$227K Buy
6,171
+674
+12% +$24.7K 0.06% 137
2020
Q3
$191K Buy
5,497
+3,444
+168% +$121K 0.06% 135
2020
Q2
$64K Buy
+2,053
New +$69.7K 0.03% 178

Other funds holding PFE

Carolinas Wealth Consulting's PFE Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Pfizer (PFE) in Q2 2025, closing a stake of 2,506 shares — an estimated $63.5K sold.

Carolinas Wealth Consulting first reported a position in PFE in Q2 2020 and held it in 20 quarters. The position peaked at $238K in Q2 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 2,506 Pfizer shares in Q2 2025, an estimated $63.5K.
  • Carolinas Wealth Consulting first reported a position in Pfizer in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Pfizer position peaked at $238K in Q2 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.